WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹1.91 Cr | ₹-21 Cr | ₹13 Cr | ₹7.34 Cr | ₹-0.08 Cr |
What is the latest Net Cash Inflow / Outflow ratio of WANBURY ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹1.91 Cr |
Mar2023 | ₹-21 Cr |
Mar2022 | ₹13 Cr |
Mar2021 | ₹7.34 Cr |
Mar2020 | ₹-0.08 Cr |
How is Net Cash Inflow / Outflow of WANBURY Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹1.91 Cr | Positive | |
Mar2023 | ₹-21 Cr | Negative | |
Mar2022 | ₹13 Cr | 70.64 | |
Mar2021 | ₹7.34 Cr | Positive | |
Mar2020 | ₹-0.08 Cr | - |
Compare Net Cash Inflow / Outflow of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹842.9 Cr | -3.9% | 2.5% | 10.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹384,469.0 Cr | 0.5% | -2.3% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,672.0 Cr | 0.9% | -0.8% | 10.8% | Stock Analytics | |
CIPLA | ₹125,034.0 Cr | -0.3% | -0.9% | -3.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,542.0 Cr | -3% | -2.4% | 3.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,571.0 Cr | 0.6% | 3.9% | -0.4% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -3.9% |
2.5% |
10.1% |
SENSEX | 1.2% |
1.9% |
-0.2% |
You may also like the below Video Courses